Earnings1Q EBITDA of $131M was ahead of consensus, with impressive revenue rising 25.9%, largely on strength across Pharmacy Solutions.
GuidanceBTSG raised its 2025-26 EBITDA forecasts, indicating confidence in future financial performance and further reinforcing the positive outlook.
StrategyThe company's efforts to reduce leverage have been accelerated by the sale of Rescare, which is part of the company's strategy to improve its financial profile.